论文部分内容阅读
传统观点认为多发性硬化(MS)是一种中枢神经系统的自身免疫性炎性脱髓鞘疾病,常采用免疫抑制和抗炎治疗。随着对MS发病机制研究的深入,许多新的治疗策略被用于MS的治疗。MS疾病修正治疗已尝试进行MS发病的特异性靶点治疗,而对进展性MS则采用神经保护和神经修复治疗。与当前的治疗措施相比,新的治疗方案对控制MS复发更有效,但也带来一定的风险。目前仍在积极寻找进展性MS的有效治疗手段。
The traditional view that multiple sclerosis (MS) is a central nervous system autoimmune inflammatory demyelinating disease, often using immunosuppressive and anti-inflammatory treatment. With the further study of the pathogenesis of MS, many new therapeutic strategies are used for the treatment of MS. MS disease-modifying therapies Attempts have been made to target specific MS-onset diseases, while neurostimulation and neurorestoratology are used for progressive MS. Compared with the current treatment, the new treatment regimen is more effective in controlling MS relapse, but it also brings some risks. It is still actively seeking effective treatment of progressive MS.